{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T21:47:55Z","timestamp":1787089675091,"version":"build-2736575974"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162138","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T14:57:29Z","timestamp":1473433049000},"page":"e0162138","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India"],"prefix":"10.1371","volume":"11","author":[{"given":"Salil","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinalini","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay","family":"Laxmeshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Jonckheere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sein Sein","family":"Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Isaakidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1128\/AAC.47.1.416-417.2003","article-title":"In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs","volume":"47","author":"L Alcala","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1183\/09031936.00035114","article-title":"Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China","volume":"45","author":"S Tang","year":"2015","journal-title":"Eur Respir J"},{"issue":"16","key":"ref3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","article-title":"Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis","volume":"367","author":"M Lee","year":"2012","journal-title":"N Engl J Med"},{"key":"ref4","unstructured":"WHO treatment guidelines for drug-resistant tuberculosis 2016 update. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/areas-of-work\/drug-resistant-tb\/treatment\/resources\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/areas-of-work\/drug-resistant-tb\/treatment\/resources\/en\/<\/ext-link>"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/bjo.2006.102541","article-title":"Linezolid-induced optic neuropathy: a mitochondrial disorder?","volume":"91","author":"M Javaheri","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/01.wnl.0000201313.24970.b8","article-title":"Linezolid-associated toxic optic neuropathy","volume":"66","author":"JC Rucker","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/648675","article-title":"Linezolid in the treatment of multidrug-resistant tuberculosis","volume":"50","author":"GF Schecter","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1183\/09031936.00132009","article-title":"Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective","volume":"35","author":"ZF Udwadia","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1183\/09031936.00188114","article-title":"Linezolid for multidrug-resistant tuberculosis in HIV-infected and\u2013uninfected patients","volume":"46","author":"J Hughes","year":"2015","journal-title":"Eur Respir J"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1183\/09031936.00022912","article-title":"Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis","volume":"40","author":"G Sotgiu","year":"2012","journal-title":"Eur Respir J"},{"issue":"4","key":"ref11","first-page":"603","article-title":"Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis","volume":"7","author":"X Zhang","year":"2015","journal-title":"J Thorac Dis"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"e28066","DOI":"10.1371\/journal.pone.0028066","article-title":"Mansoor H et al. Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India","volume":"6","author":"P Isaakidis","year":"2011","journal-title":"PloS ONE"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"e40781","DOI":"10.1371\/journal.pone.0040781","article-title":"Adverse events among HIV\/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India","volume":"7","author":"P Isaakidis","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajo.2004.11.047","article-title":"Linezolid-induced optic neuropathy","volume":"139","author":"T Saijo","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09273948.2013.874447","article-title":"Optic neuropathy secondary to Linezolid for multidrug-resistant mycobacterial spinal tuberculosis","volume":"23","author":"R Agrawal","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4103\/0301-4738.118451","article-title":"Linezolid-induced optic neuropathy","volume":"62","author":"D Karuppannasamy","year":"2014","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/WNO.0b013e31829b4265","article-title":"Linezolid-associated optic neuropathy in a patient with drug-resistant tuberculosis","volume":"33","author":"J Han","year":"2013","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10384-009-0678-3","article-title":"Linezolid-associated optic neuropathy in a patient with ocular sarcoidosis","volume":"53","author":"K Kiuchi","year":"2009","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1086\/603592","article-title":"Optic neuropathy following linezolid use in a patient with acute lymphocytic leukemia","volume":"49","author":"KO Cleveland","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1086\/597298","article-title":"A case of optic neuropathy after short-term linezolid use in a patient with acute lymphocytic leukemia","volume":"48","author":"L Joshi","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/bjo.2005.074237","article-title":"Linezolid induced toxic optic neuropathy","volume":"89","author":"K Kulkarni","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00041327-200503000-00005","article-title":"Optic neuropathy associated with linezolid treatment","volume":"25","author":"SH McKinley","year":"2005","journal-title":"J Neuroophthalmol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/379012","article-title":"Linezolid-associated toxic optic neuropathy: a report of 2 cases","volume":"37","author":"E Lee","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/WNO.0b013e318205a148","article-title":"Bitemporal visual field defects in ethambutol-induced optic neuropathy","volume":"31","author":"RC Kho","year":"2011","journal-title":"J Neuroophthalmol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T18:19:16Z","timestamp":1540232356000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162138"}},"subtitle":[],"editor":[{"given":"Sanjoy","family":"Bhattacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162138","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}